
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

39232052
71592
10.1038/s41598-024-71592-z
Article
Construction and validation of nomogram to predict surgical site infection after hysterectomy: a retrospective study
Shao Hui 1
Wang Xiujuan 1
Feng Lili fenglili19850310@163.com

2
1 Department of Infectology, Shaoxing Maternity and ChildHealth Care Hospital, Shaoxing, China
2 Department of Anesthesiology, Shaoxing Maternity and ChildHealth Care Hospital, Shaoxing, China
4 9 2024
4 9 2024
2024
14 2053825 12 2023
29 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
This study aimed to develop a predictive tool for surgical site infections (SSI) following hysterectomy and propose strategies for their prevention and control. We conducted a retrospective analysis at a tertiary maternity and child specialist hospital in Zhejiang Province, focusing on patients who underwent hysterectomy between January 2018 and December 2023 for gynecological malignancies or benign reproductive system diseases resistant to medical treatment. Risk factors associated with surgical site infections (SSI) following hysterectomy were identified using LASSO regression analysis on data from 2018 to 2022 as the training set. Independent risk factors were then used to develop a nomogram. The model was validated using data from 2023 as the validation set. Model performance was assessed using the area under the receiver operating characteristic curve (ROC), while calibration curves were employed to gauge model accuracy. Furthermore, clinical utility was evaluated through clinical decision curve analysis (DCA) and clinical impact curve analysis (CIC), providing insights into the practical application of the nomogram. Multivariate analysis identified six independent risk factors associated with SSI development after hysterectomy: BMI ≥ 24 kg/m2 (OR: 2.58; 95% CI 1.14–6.19; P < 0.05), hypoproteinaemia diagnosis (OR: 4.99; 95% CI 1.95–13.02; P < 0.05), postoperative antibiotic use for ≥ 3 days (OR: 49.53; 95% CI 9.73–91.01; P < 0.05), history of previous abdominal surgery (OR: 7.46; 95% CI 2.93–20.01; P < 0.05), hospital stay ≥ 10 days (OR: 9.67; 95% CI 2.06–76.46; P < 0.05), and malignant pathological type (OR: 4.62; 95% CI 1.78–12.76; P < 0.05). A nomogram model was constructed using these variables. ROC and calibration curves demonstrated good model calibration and discrimination in both training and validation sets. Analysis with DCA and CIC confirmed the clinical utility of the nomogram. Personalized nomogram mapping for SSI after hysterectomy enables early identification of high-risk patients, facilitating timely interventions to reduce SSI incidence post-surgery.

Keywords

Hysterectomy
Surgical site infection
Hospital-acquired infection
LASSO regression
Subject terms

Diseases
Medical research
Risk factors
issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

Surgical site infections (SSI) are prevalent among healthcare-associated infections1, contributing significantly to morbidity, prolonged hospital stays, and increased healthcare costs2,3. Hysterectomy is one of the most common gynecological surgeries, involving the removal of the uterine corpus, cervix, both fallopian tubes, and both ovaries. This procedure can be performed abdominally, laparoscopically, or vaginally, categorized clinically as laparoscopic-assisted hysterectomy (LH), transabdominal hysterectomy (TAH), or vaginal hysterectomy (VH). Currently, laparoscopic hysterectomy is the predominant approach, with varying incidence rates of postoperative SSI observed globally4–6.

It is crucial to note that all types of hysterectomy carry inherent risks of SSI, regardless of the surgical method chosen. These infections stem from factors such as postoperative pain and psychological stress, contributing to extended hospital stays and heightened healthcare expenditures. Previous studies23,24 have identified multiple independent risk factors associated with SSI post-hysterectomy; however, translating these findings into clinical practice remains challenging. Developing a straightforward predictive tool could enhance the identification of these risk factors, thereby facilitating better clinical decision-making in SSI prevention and management.

The nomogram, a graphical representation simplifying statistical equations, has emerged as a reliable method for assessing SSI risk. Despite its utility, its application in predicting SSI among hysterectomy patients remains relatively unexplored. Hence, our study sought to develop and validate a nomogram using readily available hospital data, encompassing admission details, laboratory results, pathology type, blood transfusion status, surgical specifics, and antibiotic usage. This nomogram aims to swiftly screen patients suspected to be at high risk of SSI, providing a valuable resource for clinical assessment and early intervention. This research represents a pioneering effort in China to advance the understanding and management of SSI risks in hysterectomy patients.

Methods

Type and medium of study

This retrospective observational study was conducted at the Shaoxing Women's and Children's Hospital, a tertiary specialist hospital affiliated to the Shaoxing Academy of Arts and Sciencesin eastern China, which has a bed capacity of 600, including four gynaecology wards with a total of 160 beds.

The study population

The study encompassed a population of 635 patients, including both those who developed surgical site infections (SSI) following hysterectomy and those who did not, within the period from January 2018 to December 2023. Patient inclusion criteria were defined as follows: (1) SSI diagnosis adhering to the Technical Guidelines for Prevention and Control of Surgical Site Infections and Diagnosis of Hospital Infections issued by the National Health and Wellness Commission7, which encompassed infections in the subcutaneous tissue, incisional skin, fascia, and muscle layers occurring within 30 days post-surgery; (2) Absence of severe cardiac, pulmonary, hepatic, or renal dysfunction; (3) Patients undergoing total hysterectomy. Patient exclusion criteria entailed: (1) Incomplete hysterectomy procedures; (2) Insufficient clinical information available; (3) Patients with infections of the vaginal vault.

Data collection

We conducted a retrospective collection of clinical and laboratory data obtained at admission from our electronic medical records system. The variables included age at admission, menopausal status, BMI at admission, presence of indwelling drains for lymphatic tissue drainage, preoperative hypertension status, preoperative anemia status, and preoperative hypo-proteinemia defined as total plasma protein less than 60 g/L with albumin less than 30 g/L. Additional variables collected were preoperative white blood cell count, duration of postoperative antimicrobial treatment, use of additional intraoperative antibiotics, surgical mode and duration, American Society of Anesthesiologists (ASA) classification, intraoperative blood loss, history of previous abdominal surgeries, total hospitalization days, pathology type (benign or malignant), adnexal resection (ovary or tubal), pelvic or aortic lymph node resection, and intraoperative blood transfusion status (including autologous or allogeneic transfusion). Also includes type of incision (whether midline or not). Patients were monitored for surgical site infections (SSI) through our hospital's infection surveillance system.

Statistical analysis

The data were initially assessed for normality using the Kolmogorov–Smirnov test and for homogeneity of variances using Bartlett's chi-square test. Categorical variables were presented as counts and percentages where appropriate. The training set underwent analysis using the Least Absolute Shrinkage and Selection Operator (LASSO) regression model to identify predictive risk factors with non-zero coefficients. Subsequently, based on these selected risk factors, multivariate logistic regression analyses were conducted to identify independent predictors. This led to the development of a nomogram model aimed at predicting the likelihood of surgical site infections (SSI) following hysterectomy. Validation of the model was performed using an independent dataset from 2023. The discriminative ability and calibration of the model were evaluated using receiver operating characteristic (ROC) curves and calibration plots, respectively. Additionally, Decision Curve Analysis (DCA) and Clinical Impact Curve (CIC) were employed to assess the clinical utility and net benefit of the predictive model. Statistical significance was set at a two-sided P-value of less than 0.05. All analyses were carried out using R software version 4.2.2, with relevant packages including "readr", "compareGroups", "tableone", "glmnet", "foreign", "rms", "rmda", "pROC", and "ggplot2".

Results

Population baseline characteristics

A total of 635 patients who underwent trans-hysterectomy met the inclusion criteria. Table 1 presents thebasic characteristics of these patients, among whom the incidence of surgical site infection was 9.45% (60/635). Continuous variables such as age, BMI, preoperative leukocyte count, duration of postoperative antibiotics, surgery duration, blood loss, and total hospital days were categorized using median or near-median values as thresholds.Among the patients included in the study, 360 individuals (56.7%, 360/635) were aged 52 years or older. Menopausal status was noted in 45.0% (286/635) of patients, while 52.9% (336/635) had a BMI ≥ 24 kg/m2. Other notable percentages included 18.6% (118/635) with an indwelling drain, 18.3% (167/635) with hypertension, 19.5% (124/635) with anaemia, and 9.13% (58/635) with hypoproteinaemia. Furthermore, 40.8% (259/635) of patients received ≥ 3 days of postoperative antibiotics, and 6.61% (42/635) received additional intraoperative antibiotics. Laparoscopic surgery was performed in 60.2% (382/635) of cases. Operations lasting ≥ 105 min accounted for 52.6% (334/635), and 70.6% (448/635) of patients were classified as ASA II-III. Operative blood loss exceeded 50 ml in 33.1% (210/635) of patients, and 15.1% (96/635) had a history of previous abdominal surgery.Regarding hospital stay, 61.6% (391/635) of patients remained hospitalized for ≥ 10 days. Pathologically confirmed malignant tumors were present in 29.0% (184/635), and adnexal resection was performed in 89.1% (566/635) of cases. Pelvic or aortic lymphadenectomy was performed in 16.2% (103/635) of patients, and 11.7% (74/635) received intraoperative blood transfusions. Additionally, 10.7%(66/635) of patients with an open abdomen underwent a midline incision type. Baseline comparisons across twelve variables showed significant differences (p < 0.05). Table 2 presents the patient demographics divided into training and validation sets. The training set included data from 544 patients (January 2018 to December 2022), with 48 cases of surgical site infections, while the validation set comprised 91 patients from 2023, with 12 infections reported. Table 1 Demographic and clinical characteristics of hysterectomized patients.

Vriable	ALL	SSI	Non- SSI	p	
	N = 635	N = 60	N = 575		
Age(years)				0.336	
< 52	275 (43.3%)	30 (50.0%)	245 (42.6%)		
≥ 52	360 (56.7%)	30 (50.0%)	330 (57.4%)		
Menopause				0.132	
Yes	286 (45.0%)	21 (35.0%)	265 (46.1%)		
No	349 (55.0%)	39 (65.0%)	310 (53.9%)		
BMI(kg/m2)				0.008	
< 24	299 (47.1%)	18 (30.0%)	281 (48.9%)		
≥ 24	336 (52.9%)	42 (70.0%)	294 (51.1%)		
Abdominal drainage tube				 < 0.001	
Yes	118 (18.6%)	27 (45.0%)	91 (15.8%)		
No	517 (81.4%)	33 (55.0%)	484 (84.2%)		
Hypertension				0.482	
Yes	167 (26.3%)	13 (21.7%)	154 (26.8%)		
No	468 (73.7%)	47 (78.3%)	421 (73.2%)		
Anaemia				0.102	
Yes	124 (19.5%)	17 (28.3%)	107 (18.6%)		
No	511 (80.5%)	43 (71.7%)	468 (81.4%)		
Hypoproteinemia				 < 0.001	
Yes	58 (9.1%)	26 (43.3%)	32 (5.6%)		
No	577 (90.9%)	34 (56.7%)	543 (94.4%)		
Pre-operative WBC(10^9/L)					
				0.549	
< 5.4	325 (51.2%)	28 (46.7%)	297 (51.7%)		
≥ 5.4	310 (48.8%)	32 (53.3%)	278 (48.3%)		
Timing of postoperativeantimicrobial use(days)				 < 0.001	
< 3	376 (59.2%)	6 (10.0%)	370 (64.3%)		
≥ 3	259 (40.8%)	54 (90.0%)	205 (35.7%)		
Additional intraoperative antibiotics				0.004	
Yes	42 (6.6%)	10 (16.7%)	32 (5.6%)		
No					
No	593 (93.4%)	50 (83.3%)	543 (94.4%)		
Surgical approach				 < 0.001	
LH	382 (60.2%)	34 (56.7%)	348 (60.5%)		
VH	187 (29.4%)	11 (18.3%)	176 (30.6%)		
TAH	66 (10.4%)	15 (25.0%)	51 (8.9%)		
Duration of surgery(min)				0.106	
< 105	301 (47.4%)	22 (36.7%)	279 (48.5%)		
≥ 105	334 (52.6%)	38 (63.3%)	296 (51.5%)		
ASA				0.805	
I	187 (29.4%)	19 (31.7%)	168 (29.2%)		
II-III	448 (70.6%)	41 (68.3%)	407 (70.8%)		
Surgical blood loss (ml)				0.179	
 ≤ 50	425 (66.9%)	35 (58.3%)	390 (67.8%)		
 > 50	210 (33.1%)	25 (41.7%)	185 (32.2%)		
Previous abdominal surgery				 < 0.001	
Yes	96 (15.1%)	26 (43.3%)	70 (12.2%)		
No	539 (84.9%)	34 (56.7%)	505 (87.8%)		
Total hospital days				 < 0.001	
< 10	244 (38.4%)	5 (8.3%)	239 (41.6%)		
≥ 10	391 (61.6%)	55 (91.7%)	336 (58.4%)		
Type of pathology				 < 0.001	
Benign disease	451 (71.0%)	18 (30.0%)	433 (75.3%)		
Malignant disease	184 (29.0%)	42 (70.0%)	142 (24.7%)		
Adnexectomy				0.194	
Yes	566 (89.1%)	50 (83.3%)	516 (89.7%)		
No	69 (10.9%)	10 (16.7%)	59 (10.3%)		
Pelvic or aortic lymphadenectomy				 < 0.001	
Yes	103 (16.2%)	21 (35.0%)	82 (14.3%)		
No	532 (83.8%)	39 (65.0%)	493 (85.7%)		
Intraoperative blood transfusion				0.524	
Yes	74 (11.7%)	9 (15.0%)	65 (11.3%)		
No	561 (88.3%)	51 (85.0%)	510 (88.7%)		
Midline incision					
Yes	66 (10.4%)	15 (25.0%)	51 (8.9%)	 < 0.001	
No	569(89.6%)	45 (75.0%)	524(91.1%)		

Table 2 Baseline information grouped by training and validation sets.

Vriable	ALL	Training Cohort	Validation Cohort	P	
	N = 635	N = 544	N = 91		
Age (years)				0.003	
< 52	275 (43.3%)	249 (45.8%)	26 (28.6%)		
≥ 52	360 (56.7%)	295 (54.2%)	65 (71.4%)		
Menopause				0.209	
Yes	286 (45.0%)	239 (43.9%)	47 (51.6%)		
NO	349 (55.0%)	305 (56.1%)	44 (48.4%)		
BMI(kg/m2)				0.291	
< 24	299 (47.1%)	251 (46.1%)	48 (52.7%)		
≥ 24	336 (52.9%)	293 (53.9%)	43 (47.3%)		
Abdominal drainage tube				0.181	
Yes	118 (18.6%)	96 (17.6%)	22 (24.2%)		
No	517 (81.4%)	448 (82.4%)	69 (75.8%)		
Hypertension				0.162	
Yes	167 (26.3%)	149 (27.4%)	18 (19.8%)		
No	468 (73.7%)	395 (72.6%)	73 (80.2%)		
Anaemia				0.621	
Yes	124 (19.5%)	104 (19.1%)	20 (22.0%)		
No	511 (80.5%)	440 (80.9%)	71 (78.0%)		
Hypoproteinemia				0.100	
Yes	58 (9.1%)	45 (8.3%)	13 (14.3%)		
No	577 (90.9%)	499 (91.7%)	78 (85.7%)		
Pre-operative WBC(10^9/L)					
				0.663	
< 5.4	325 (51.2%)	276 (50.7%)	49 (53.8%)		
≥ 5.4	310 (48.8%)	268 (49.3%)	42 (46.2%)		
Timing of postoperativeantimicrobial use (days)				0.887	
< 3	376 (59.2%)	321 (59.0%)	55 (60.4%)		
≥ 3	259 (40.8%)	223 (41.0%)	36 (39.6%)		
Additional intraoperative antibiotics				0.012	
Yes	42 (6.6%)	30 (5.5%)	12 (13.2%)		
No	593 (93.4%)	514 (94.5%)	79 (86.8%)		
Surgical approach				0.001	
LH	382 (60.2%)	343 (63.1%)	39 (42.9%)		
VH	187 (29.4%)	147 (27.0%)	40 (44.0%)		
TAH	66 (10.4%)	54 (9.9%)	12 (13.2%)		
Duration of surgery(min)				0.083	
 < 105	301 (47.4%)	266 (48.9%)	35 (38.5%)		
 ≥ 105	334 (52.6%)	278 (51.1%)	56 (61.5%)		
ASA				0.118	
I	187 (29.4%)	167 (30.7%)	20 (22.0%)		
II-III	448 (70.6%)	377 (69.3%)	71 (78.0%)		
Surgical blood loss (ml)				1.000	
≤ 50	425 (66.9%)	364 (66.9%)	61 (67.0%)		
> 50	210 (33.1%)	180 (33.1%)	30 (33.0%)		
Previous abdominal surgery				0.134	
Yes	96 (15.1%)	77 (14.2%)	19 (20.9%)		
No	539 (84.9%)	467 (85.8%)	72 (79.1%)		
Total hospital days				0.026	
< 10	244 (38.4%)	199 (36.6%)	45 (49.5%)		
≥ 10	391 (61.6%)	345 (63.4%)	46 (50.5%)		
Type of pathology				 < 0.001	
Benign disease	451 (71.0%)	402 (73.9%)	49 (53.8%)		
Malignant disease	184 (29.0%)	142 (26.1%)	42 (46.2%)		
Adnexectomy				0.189	
Yes	566 (89.1%)	489 (89.9%)	77 (84.6%)		
No	69 (10.9%)	55 (10.1%)	14 (15.4%)		
Pelvic or aortic lymphadenectomy				1.000	
Yes	103 (16.2%)	88 (16.2%)	15 (16.5%)		
No	532 (83.8%)	456 (83.8%)	76 (83.5%)		
Intraoperative blood transfusion				0.015	
Yes	74 (11.7%)	56 (10.3%)	18 (19.8%)		
No	561 (88.3%)	488 (89.7%)	73 (80.2%)		
Midline incision				0.449	
Yes	66 (10.4%)	54 (9.9%)	12 (13.2%)		
No	569 (89.6%)	490 (90.1%)	79 (86.8%)		
SSI				0.261	
Yes	60 (9.4%)	48 (8.8%)	12 (13.2%)		
No	575 (90.6%)	496 (91.2%)	79 (86.8%)		

LASSO regression and multivariate analysis

LASSO regression was employed to identify risk factors associated with surgical site infections (SSI) in transhysterectomy patients. Initially, 21 variables were subjected to LASSO regression, resulting in 12 potential predictors highlighted in the coefficient profiles (Fig. 1A). The model's performance was validated through a cross-validated error plot (Fig. 1B). Notably, the final LASSO model incorporated predictors such as menopausal status, BMI, presence of indwelling drains, hypoproteinaemia, duration of postoperative antimicrobial use, use of intraoperative antibiotics, surgical duration, ASA classification, history of previous abdominal surgery, total hospital days, and pathological diagnosis of malignant tumors or adnexectomy.Subsequent multifactorial logistic regression analysis, following the LASSO screening, revealed six independent predictors significantly associated with SSI (Table 3). These included BMI ≥ 24 kg/m2 (OR: 2.58; 95% CI 1.14–6.19; P < 0.05), hypoproteinaemia (OR: 4.99; 95% CI 1.95–13.02; P < 0.05), postoperative antibiotic use for ≥ 3 days (OR: 49.53; 95% CI 9.73–91.01; P < 0.05), history of previous abdominal surgery (OR: 7.46; 95% CI 2.93–20.01; P < 0.05), total hospital stay of ≥ 10 days (OR: 9.67; 95% CI 2.06–76.46; P < 0.05), and pathological diagnosis of malignant tumors (OR: 4.62; 95% CI 1.78–12.76; P < 0.05).Fig. 1 (A) 12 variables screened from 21 based on LASSO regression.A coefficient profile plot was produced against the log (λ) sequence. (B) Plot of the results of cross-validation, and the red dots in the figure represent the target parameters corresponding to each lambda.

Table 3 Multivariate regression model based on LASSO regression results.

Variable	Estimate	Std.Error	OR (95%CI)	P-value	
BMI	0.9492	0.4290	2.58(1.14–6.19)	 < 0.05	
Hypoproteinemia	1.6080	0.4812	4.99(1.95–13.02)	 < 0.05	
Timing of postoperativeantimicrobial use	3.9027	1.0472	49.53(9.73–91.01)	 < 0.05	
Previous abdominal surgery	2.0093	0.4860	7.46(2.93–20.01)	 < 0.05	
Total hospital days	2.2688	0.8926	9.67(2.06–76.46)	 < 0.05	
Type of pathology	1.5315	0.4994	4.62(1.78–12.76)	 < 0.05	
OR = odds ratio;CI = confidence interval;*p < 0.05.

Individualised predictive model construction nomogram

The final selection of six variables was incorporated into a nomogram to construct a predictive model forsurgical site infections (SSI) following total hysterectomy, using R 4.2.2 (Fig. 2). Each variable was assigned points by projecting upward along a straight line to the points axis. The total score was then plotted on the axis representing total points, and a line was drawn downward to the probability axis, indicating the likelihood of an SSI. Patients were scored based on the nomogram, with a maximum score of 450 points. In Fig. 3, red dots represent observed values for each variable in the patient from the second row of the study dataset. For instance, this patient had a BMI ≥ 24, hypoproteinemia, no history of abdominal surgery, a malignant tumor pathology, days of a hospital stay ≥ 10, days of postoperative antibiotics ≥ 3, and a total score of 392 points. According to the nomogram, this score corresponds to a probability of 0.672 for developing a surgical site infection.Fig. 2 Nomogram to predict the risk of surgical site infection in hysterectomized patients.

Fig. 3 (A) Received Operating Characteristic Curve (ROC) for the training set; (B) Received Operating Characteristic Curve (ROC) for the validation set.

Internal and external validation

The model's performance was assessed through ROC curves and calibration plots, yielding an area under the ROC curve (AUC) of 0.935 for the training set (Fig. 3A) and 0.877 for the validation set (Fig. 3B). Calibration curves in both sets (Fig. 4A,B) demonstrated close alignment between predicted and observed rates, indicating reliable predictive accuracy.Fig. 4 (A) Calibration plot of the training set. (B) Calibration plot for the validation set. The x-axis represents the predicted probability of SSI infection by the nomogram, and the y-axis represents the actual infection rate of SSI. The 45-degree reference line signifies perfect calibration.

Clinical Use of the nomogram

To assess the model's performance beyond ROC curves, we analyzed clinical decision curves (DCA) for the training and validation sets, each based on 635 transhysterectomy patients. The DCA illustrated significant net gains across a broad spectrum of high-risk thresholds, affirming the nomogram's efficacy (Fig. 5A,C). Additionally, clinical impact curves (CIC) were plotted. The red curve depicts individuals classified as positive (high risk) by the model at various probability thresholds, while the blue curve shows true positives at each threshold. These curves provide a clearer visual representation of the nomogram's overall benefit (Fig. 5B,D).Fig. 5 (A) Decision curve analysis (DCA) of the training set, (B) Clinical impact curve (CIC) analysis of the training set, (C) Decision curve analysis (DCA) of the validation set, (D) Clinical impact curve (CIC) analysis of the validation set.

Discussion

Surgical site infection (SSI) presents a significant challenge following hysterectomy, leading to prolonged hospital stays and increased healthcare costs. Internationally, SSI data from hysterectomies are used to assess hospital care quality, with potential financial penalties for hospitals exceeding certain infection thresholds in terms of insurance reimbursement8. Previous studies underscore that SSI rank among the costliest hospital-acquired infections in the United States, adding up to $10 billion annually9,10. Patients with SSI experience a three- to five-fold longer hospital stay, double the healthcare costs, and a three-fold higher risk of rehospitalization compared to those without SSI.In our hospital, we initially identified 21 potential variables associated with SSI development post-hysterectomy. Through rigorous LASSO and multivariate regression analyses, which mitigate covariance between variables11, we pinpointed six critical factors: BMI ≥ 24, hypoproteinemia diagnosis, ≥ 3 days of postoperative antibiotics, history of abdominal surgery, total hospital days ≥ 10, and malignancy pathology type.Based on these six independent risk factors, we developed a predictive model designed as a practical and effective tool for anticipating the likelihood of postoperative SSI in hysterectomy patients within clinical settings. We assessed the model's performance using ROC and calibration curves, demonstrating its robust predictive accuracy for SSI occurrence post-hysterectomy. Furthermore, findings from decision curve analysis (DCA) and clinical impact curve (CIC) plots underscored the model's favorable net clinical benefit. To enhance usability, we created a nomogram enabling clinicians to swiftly gauge a patient's SSI risk following hysterectomy, streamlining assessment without computational complexity.

The duration of postoperative antimicrobial use holds significant weight in our nomogram, highlighting its paramount importance as an independent risk factor for SSI in hysterectomy patients compared to others. This duration encompasses both perioperative prophylaxis and therapeutic antibiotic use, with perioperative administration typically lasting up to 48 h post-surgery. Prolonged therapeutic antimicrobial use beyond 48 h correlates with changes in specific inflammatory markers like procalcitoninogen (PCT) and C-reactive protein, indicating an increased risk of developing surgical site infections. Hypoproteinemia is an independent risk factor for postoperative surgical site infections (SSI). Before surgery, hypoproteinemia results in inadequate protein reserves, lowering the body's stress tolerance and immune function. This impairment hinders post-surgical tissue healing and diminishes infection resistance, thereby escalating the likelihood of complications, disease progression, and mortality12. Research outcomes consistently advocate for sustained and tailored preoperative nutritional support as pivotal in lowering the incidence of SSI in such patients13–15. The duration of hospitalization emerged as an independent risk factor in our study. Our analysis also incorporated preoperative hospital days, which exhibited a statistically significant correlation with postoperative surgical site infections (SSI), consistent with prior research16,17.

The investigation of surgical complications following hysterectomy remains a prominent research area. Our study specifically focuses on postoperative SSI, while previous studies, such as Schmidt et al18, have developed and validated tools for assessing preoperative clinical risks associated with complications occurring within 30 days post-hysterectomy, encompassing a broad spectrum that includes SSI among others. Schmidt et al. expanded their assessment to include post-hysterectomy complications related to malignant conditions, in addition to benign gynecological conditions previously studied19. Their findings identified three modifiable factors to mitigate postoperative complications: opting for minimally invasive hysterectomy, improving glycemic control, and avoiding preoperative blood transfusions. They also highlighted that BMI > 40, gynecological cancers, and a history of prior abdominal surgery independently increase the risk of postoperative complications, findings that parallel our study results to some extent. Sloth20 et al. formulated clinical guidelines for hysterectomy in Denmark. Their study concluded that there were no significant differences in outcomes between subtotal and total hysterectomy. They found that variations in operative time, intraoperative bleeding, and postoperative infections were minimal and lacked statistical significance. Additionally, the research highlighted that hysterectomy combined with bilateral salpingo-oophorectomy was associated with a reduced risk of postoperative infections. In a separate study, Bruno21 et al. developed a risk assessment model specifically for minimally invasive hysterectomy. Their analysis focused on intraoperative and postoperative complications, revealing that age, BMI, and the type of disease showed statistically significant associations with minor postoperative complications. Furthermore, BMI, history of previous surgeries, and surgeon experience were identified as factors significantly associated with major postoperative complications in their comprehensive risk assessment model.Previous studies22–24 have identified various high-risk factors associated with surgical site infections (SSI) following total hysterectomy, including surgical approach, ASA classification, and intraoperative blood loss. Additionally, Tuomi, Tserenpuntsag and Pop-Vicas25–27 concluded that the prolonged duration of surgery leads to tissue pulling damage and extended exposure of tissues and organs to air, facilitating conditions for pathogenic bacterial colonization and increasing infection risk. However, these factors did not demonstrate significant effects on postoperative SSI in the results of our study. This discrepancy may stem from differences in the study population characteristics, hospital environments, and medical care conditions.

Our study successfully developed a predictive model for postoperative SSI in patients undergoing hysterectomy. However, it is important to acknowledge some limitations due to its retrospective, single-center design. To enhance reliability, we conducted internal validation by splitting the dataset into training and validation sets. External validation of the predictive model remains necessary for broader applicability in clinical settings. In conclusion, our predictive model based on LASSO regression analysis demonstrated strong predictive efficiency for predicting SSI in hysterectomy patients. This tool holds promise for early identification of high-risk patients and could contribute to refining treatment protocols in clinical practice.

Conclusions

In our study, we identified BMI ≥ 24 kg/m2, hypoproteinemia diagnosis, postoperative antibiotic duration ≥ 3 days, history of prior abdominal surgery, total hospital stay ≥ 10 days, and malignancy pathology as independent risk factors for postoperative surgical site infections (SSI) in total hysterectomy patients. Developing a nomogram using these factors, characterized by simplicity and applicability, demonstrates strong predictive ability. Such a tool holds promise for informing clinical decisions and optimizing treatment strategies.

Supplementary Information

Supplementary Information.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-024-71592-z.

Author contributions

Hui Shao: data analysis,writingthe paper. Lili Feng:study design, manuscript preparation.XiujuanWang:data collection and assessment, manuscript preparation. All authors read and approved the final manuscript.

Data availability

The data related to this study has been made to be uploaded as supporting information.

Competing interests

The authors declare no competing interests.

Ethics approval

The authors assert that they have secured proper approval from the Ethics Committee of Nanjing Medical University and have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. Our study was reported as described by the ARRIVE guidelines (Ethics approval reference number: 20210329).

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Magill SS Multistate point-prevalence survey of health care-associated infections New. Engl. J. Med. 2014 370 13 1198 1208 10.1056/NEJMoa1306801 24670166
Magill, S. S. et al. Multistate point-prevalence survey of health care-associated infections. New. Engl. J. Med. 370(13), 1198–1208. 10.1056/NEJMoa1306801 (2014).24670166 10.1056/NEJMoa1306801
2. Poulsen KB Estimated costs of postoperative wound infections. A case-control study of marginal hospital and social security costs Epidemiol. Infect. 1994 113 2 283 295 10.1017/s0950268800051712 7925666
Poulsen, K. B. et al. Estimated costs of postoperative wound infections. A case-control study of marginal hospital and social security costs. Epidemiol. Infect. 113(2), 283–295. 10.1017/s0950268800051712 (1994).7925666 10.1017/s0950268800051712
3. Schweizer ML Costs associated with surgical site infections in veterans affairs hospitals JAMA Surg. 2014 149 6 575 581 10.1001/jamasurg.2013.4663 24848779
Schweizer, M. L. et al. Costs associated with surgical site infections in veterans affairs hospitals. JAMA Surg. 149(6), 575–581. 10.1001/jamasurg.2013.4663 (2014).24848779 10.1001/jamasurg.2013.4663
4. Salmanov AG Vaginal cuff infection after hysterectomy in Ukraine Wiad Lek 2021 74 2 196 201 10.36740/WLek202102104 33813471
Salmanov, A. G. et al. Vaginal cuff infection after hysterectomy in Ukraine. Wiad Lek 74(2), 196–201 (2021).33813471 10.36740/WLek202102104
5. Morgan DM Surgical site infection following hysterectomy: Adjusted rankings in a regional collaborative Am. J. Obstet. Gynecol. 2015 214 2 259e1 259e8 10.1016/j.ajog.2015.10.002
Morgan, D. M. et al. Surgical site infection following hysterectomy: Adjusted rankings in a regional collaborative. Am. J. Obstet. Gynecol. 214(2), 259e1-259e8. 10.1016/j.ajog.2015.10.002 (2015).10.1016/j.ajog.2015.10.002
6. Brown O Minimizing risks in minimally invasive surgery: Rates of surgical site infection across subtypes of laparoscopic hysterectomy J. Minim. Invas. Gyn. 2019 27 6 1370 1376.e1 10.1016/j.jmig.2019.10.015
Brown, O. et al. Minimizing risks in minimally invasive surgery: Rates of surgical site infection across subtypes of laparoscopic hysterectomy. J. Minim. Invas. Gyn. 27(6), 1370-1376.e1. 10.1016/j.jmig.2019.10.015 (2019).10.1016/j.jmig.2019.10.015
7. [Chinese guideline for the prevention of surgical site infection]. Zhonghua Wei Chang Wai Ke Za Zhi, 22(4), 301–314 (2019). 10.3760/cma.j.issn.1671-0274.2019.04.001.
8. Burgess A Surgical-site infection prevention after hysterectomy: Use of a consensus bundle to guide improvement J. Healthc. Qual. 2020 42 4 188 194 10.1097/JHQ.0000000000000224 31652167
Burgess, A. et al. Surgical-site infection prevention after hysterectomy: Use of a consensus bundle to guide improvement. J. Healthc. Qual. 42(4), 188–194. 10.1097/JHQ.0000000000000224 (2020).31652167 10.1097/JHQ.0000000000000224
9. Anderson DJ Strategies to prevent surgical site infections in acute care hospitals: 2014 update Infect. Cont. Hosp. Ep 2014 35 2 S66 S88 10.1017/s0899823x00193869
Anderson, D. J. et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect. Cont. Hosp. Ep 35(2), S66–S88. 10.1017/s0899823x00193869 (2014).10.1017/s0899823x00193869
10. Roy S Clinical and economic burden of surgical site infection in hysterectomy Surg. Infect. 2014 15 3 266 273 10.1089/sur.2012.163
Roy, S. et al. Clinical and economic burden of surgical site infection in hysterectomy. Surg. Infect. 15(3), 266–273. 10.1089/sur.2012.163 (2014).10.1089/sur.2012.163
11. Lu J Chrom-Lasso: A lasso regression-based model to detect functional interactions using Hi-C data Brief Bioinform. 2021 22 6 1 10.1093/bib/bbab181 33401308
Lu, J. et al. Chrom-Lasso: A lasso regression-based model to detect functional interactions using Hi-C data. Brief Bioinform. 22(6), 1. 10.1093/bib/bbab181 (2021).33401308 10.1093/bib/bbab181
12. Sung J Admission serum albumin is predicitve of outcome in critically ill trauma patients Am. Surgeon. 2004 70 12 1099 1102 10.1177/000313480407001214 15663053
Sung, J. et al. Admission serum albumin is predicitve of outcome in critically ill trauma patients. Am. Surgeon. 70(12), 1099–1102 (2004).15663053 10.1177/000313480407001214
13. Zheng HL Effects of Preoperative Malnutrition on Short- and Long-Term Outcomes of Patients with Gastric Cancer: Can We Do Better? ANN SURG ONCOL 2017 24 11 3376 3385 10.1245/s10434-017-5998-9 28699132
Zheng, H. L. et al. Effects of Preoperative Malnutrition on Short- and Long-Term Outcomes of Patients with Gastric Cancer: Can We Do Better?. ANN SURG ONCOL 24(11), 3376–3385. 10.1245/s10434-017-5998-9 (2017).28699132 10.1245/s10434-017-5998-9
14. Caburet C Impact of nutritional status at the outset of assessment on postoperative complications in head and neck cancer Eur Ann Otorhinol 2019 137 5 393 398 10.1016/j.anorl.2019.12.005
Caburet, C. et al. Impact of nutritional status at the outset of assessment on postoperative complications in head and neck cancer. Eur Ann Otorhinol 137(5), 393–398. 10.1016/j.anorl.2019.12.005 (2019).10.1016/j.anorl.2019.12.005
15. Sasaki H Risk factors for surgical site infection after soft-tissue sarcoma resection, including the preoperative geriatric nutritional risk index Nutrients 2018 10 12 1 10.3390/nu10121900
Sasaki, H. et al. Risk factors for surgical site infection after soft-tissue sarcoma resection, including the preoperative geriatric nutritional risk index. Nutrients 10(12), 1. 10.3390/nu10121900 (2018).10.3390/nu10121900
16. Cediel EG Length of preoperative hospital stay is the dominating risk factor for surgical site infection in neurosurgery: A cohort data-driven analysis Surg. Neurol. Int. 2022 13 80 10.25259/SNI_1237_2021 35399909
Cediel, E. G. et al. Length of preoperative hospital stay is the dominating risk factor for surgical site infection in neurosurgery: A cohort data-driven analysis. Surg. Neurol. Int. 13, 80. 10.25259/SNI_1237_2021 (2022).35399909 10.25259/SNI_1237_2021
17. Alemayehu MA Time to development of surgical site infection and its predictors among general surgery patients admitted at specialized hospitals in Amhara region, northwest Ethiopia: A prospective follow-up study BMC Infect. Dis. 2023 23 1 334 10.1186/s12879-023-08301-0 37198551
Alemayehu, M. A. et al. Time to development of surgical site infection and its predictors among general surgery patients admitted at specialized hospitals in Amhara region, northwest Ethiopia: A prospective follow-up study. BMC Infect. Dis. 23(1), 334. 10.1186/s12879-023-08301-0 (2023).37198551 10.1186/s12879-023-08301-0
18. Schmidt PC Development of a Preoperative Clinical Risk Assessment Tool for Postoperative Complications After Hysterectomy J. Minim. Invas. Gyn. 2021 29 3 401 408 10.1016/j.jmig.2021.10.008
Schmidt, P. C. et al. Development of a Preoperative Clinical Risk Assessment Tool for Postoperative Complications After Hysterectomy. J. Minim. Invas. Gyn. 29(3), 401–408. 10.1016/j.jmig.2021.10.008 (2021).10.1016/j.jmig.2021.10.008
19. Erekson EA Major postoperative complications after benign gynecologic surgery: A clinical prediction tool Female Pelvic. Med. Re 2012 18 5 274 280 10.1097/SPV.0b013e318263a210
Erekson, E. A. et al. Major postoperative complications after benign gynecologic surgery: A clinical prediction tool. Female Pelvic. Med. Re 18(5), 274–280. 10.1097/SPV.0b013e318263a210 (2012).10.1097/SPV.0b013e318263a210
20. Sloth SB Systematic review of the limited evidence for different surgical techniques at benign hysterectomy: A clinical guideline initiated by the Danish Health Authority Eur. J. Obstet. Gyn. R B 2017 216 169 177 10.1016/j.ejogrb.2017.07.012
Sloth, S. B. et al. Systematic review of the limited evidence for different surgical techniques at benign hysterectomy: A clinical guideline initiated by the Danish Health Authority. Eur. J. Obstet. Gyn. R B 216, 169–177. 10.1016/j.ejogrb.2017.07.012 (2017).10.1016/j.ejogrb.2017.07.012
21. Bruno M Risk assessment model for complications in minimally invasive hysterectomy: A pilot study Int. J. Environ. Res. Public Health 2022 20 1 1 10.3390/ijerph20010234 36612323
Bruno, M. et al. Risk assessment model for complications in minimally invasive hysterectomy: A pilot study. Int. J. Environ. Res. Public Health 20(1), 1. 10.3390/ijerph20010234 (2022).36612323 10.3390/ijerph20010234
22. Lake AG Surgical site infection after hysterectomy Am. J. Obstet. Gynecol. 2013 209 5 490 10.1016/j.ajog.2013.06.018
Lake, A. G. et al. Surgical site infection after hysterectomy. Am. J. Obstet. Gynecol. 209(5), 490. 10.1016/j.ajog.2013.06.018 (2013).10.1016/j.ajog.2013.06.018
23. Göksever Çelik H Risk factors for surgical site infection after hysterectomy J. Infect. Dev. Ctries 2017 11 4 355 360 10.3855/jidc.9053 28459228
Göksever Çelik, H. et al. Risk factors for surgical site infection after hysterectomy. J. Infect. Dev. Ctries 11(4), 355–360. 10.3855/jidc.9053 (2017).28459228 10.3855/jidc.9053
24. Shapiro M Risk factors for infection at the operative site after abdominal or vaginal hysterectomy New Engl. J. Med. 1982 307 27 1661 1666 10.1056/NEJM198212303072701 6755254
Shapiro, M. et al. Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. New Engl. J. Med. 307(27), 1661–1666. 10.1056/NEJM198212303072701 (1982).6755254 10.1056/NEJM198212303072701
25. Tuomi T Incidence of and risk factors for surgical site infections in women undergoing hysterectomy for endometrial carcinoma Acta Obstet. Gyn. Scan 2016 95 4 480 485 10.1111/aogs.12838
Tuomi, T. et al. Incidence of and risk factors for surgical site infections in women undergoing hysterectomy for endometrial carcinoma. Acta Obstet. Gyn. Scan 95(4), 480–485. 10.1111/aogs.12838 (2016).10.1111/aogs.12838
26. Tserenpuntsag B Risk factors for surgical site infection after abdominal hysterectomy, New York State, 2015–2018 Am J. Infect. Control 2023 51 5 539 543 10.1016/j.ajic.2023.01.016 37003562
Tserenpuntsag, B. et al. Risk factors for surgical site infection after abdominal hysterectomy, New York State, 2015–2018. Am J. Infect. Control 51(5), 539–543. 10.1016/j.ajic.2023.01.016 (2023).37003562 10.1016/j.ajic.2023.01.016
27. Pop-Vicas A Incidence and risk factors for surgical site infection post-hysterectomy in a tertiary care center Am. J. Infect. Control 2016 45 3 284 287 10.1016/j.ajic.2016.10.008 27938988
Pop-Vicas, A. et al. Incidence and risk factors for surgical site infection post-hysterectomy in a tertiary care center. Am. J. Infect. Control 45(3), 284–287. 10.1016/j.ajic.2016.10.008 (2016).27938988 10.1016/j.ajic.2016.10.008
